MedTrace Logo

Effect of Sufentanil and Ropivacaine

NCT02488291 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2020-08-12

No results posted yet for this study

Summary

The investigators study the efficacy of epidural sufentanil/ropivacaine for analgesia labor in primiparas so as to decrease perinatal complications of analgesia labor.

Conditions

  • Anesthesia Complications

Interventions

DRUG

0.25 sufentanil

with different dosage

DRUG

0.5µg/ml sufentanil

0.5µg/ml sufentanil

DRUG

0.1% ropivacaine

0.1% ropivacaine

Sponsors & Collaborators

  • Shanghai Jiao Tong University School of Medicine

    collaborator OTHER

  • Fudan University

    lead OTHER

Principal Investigators

  • Zeyong Yang, M.D. · Fudan University, Shanghai Jiaotong University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-06-30
Completion
2015-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02488291 on ClinicalTrials.gov